Printer Friendly

New Study: Otitis Externa Global Clinical Trials Review, H2, 2015.

[USPRwire, Fri Sep 18 2015] GlobalData's clinical trial report, "Otitis Externa Global Clinical Trials Review, H2, 2015" provides an overview of Otitis Externa clinical trials scenario. This report provides top line data relating to the clinical trials on Otitis Externa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Full Report Details at

- http://www.fastmr.com/prod/1046649_otitis_externa_global.aspx?afid=302

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Report Scope

* The report provides a snapshot of the global clinical trials landscape

* Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

* The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

* The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

* The Report provides enrollment trends for the past five years

* Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Get this Report

* Assists in formulating key business strategies with regards to investment

* Helps in identifying prominent locations for conducting clinical trials which saves time and cost

* Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

* Supports understanding of trials count and enrollment trends by country in global therapeutics market

* Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

* Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned in this Report: Oticpharma Ltd, Novum Pharmaceutical Research Services, Inc., Novartis AG, MerLion Pharmaceuticals Pte Ltd, Foresight Biotherapeutics, Inc., Farmoquimica S/A, Alcon, Inc., Alcon Pharma GmbH, AmpliPhi Biosciences Corporation, Acorus Therapeutics Ltd

Copyright [c] 2015 USPRwire Provided by SyndiGate Media Inc. ( Syndigate.info ).
COPYRIGHT 2015 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:USPRwire
Article Type:Report
Date:Sep 18, 2015
Words:474
Previous Article:New Market Report: Nasopharyngeal Cancer - Pipeline Review, H2 2015.
Next Article:New Study: Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |